Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The model and estimator can predict drug exposure in kidney transplant patients well.

The summit aimed to speed up finding treatments for alopecia areata.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Tofacitinib is an effective and safe treatment for alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.